Are angiotensin-converting enzyme inhibitors/angiotensin receptor blockers associated with reduced severe acute respiratory syndrome coronavirus 2 infections and improved outcomes, and does race matter?

Publication Title

Diabetes, obesity & metabolism

Authors

John Armato, Providence Little Company of Mary Cardiometabolic Center, Providence Medical Institute, Torrance, California, USAFollow
Ralph A DeFronzo
Shih-Ting Chiu, Providence, Oregon and Southwest Washington, Portland, Oregon, USAFollow
Deanna Rider, Providence, Shared Services, Missoula, Montana, USAFollow
Ronald Ruby, Providence Little Company of Mary Cardiometabolic Center, Providence Medical Institute, Torrance, California, USAFollow

Document Type

Article

Publication Date

8-16-2022

Keywords

oregon; montana; covid-19; diversity

Area of Special Interest

Kidney & Diabetes

Area of Special Interest

Cardiovascular (Heart)

Specialty/Research Institute

Endocrinology

Specialty/Research Institute

Population Health

Specialty/Research Institute

Infectious Diseases